KO
Keith Orford
Director

Keith Orford insider trades: Calithera Biosciences (CALA) stock sales

Director, Calithera Biosciences Last trade Nov 11, 2021 22 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2017
1
Company
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Keith reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 11, 2021CALA↓ Sell$68K
Nov 9, 2021CALA↓ Sell$44K
Dec 16, 2020CALA↓ Sell$15K
Feb 20, 2020CALA↓ Sell$24K
Dec 23, 2019CALA↓ Sell$18K
Jun 17, 2019CALA↓ Sell$3K
May 22, 2019CALA↓ Sell$2K
Apr 15, 2019CALA↓ Sell$3K
Mar 15, 2019CALA↓ Sell$3K
Mar 11, 2019CALA↓ Sell$9K
Oct 15, 2018CALA↓ Sell$2K
Oct 11, 2018CALA↓ Sell$8K
Jul 17, 2017CALA↓ Sell$39K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Keith Orford's insider trades

Keith Orford is a director at Calithera Biosciences (CALA). Since Jul 17, 2017, Keith has reported no open-market purchases and 13 sales worth $237K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (10 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CALA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.